Pfizer near deal to buy cancer drug firm Medivation for almost $14 billion: Sources

August 22, 2016 12:25 AM

33 0

Pfizer near deal to buy cancer drug firm Medivation for almost $14 billion: Sources

Pfizer is in advanced talks to acquire U.S. cancer drug company Medivation for close to $14 billion, as it seeks to boost its oncology portfolio, people familiar with the matter said on Sunday.

Pfizer has agreed to pay a little more than $80 per share for Medivation, one of the people said, a substantial premium to the $52.50 offer for Medivation that France's Sanofi made in April, which eventually resulted in the company putting itself up for sale. Medivation shares ended trading in New Y...

Also read: Huntsman Strikes Merger Deal With Clariant, Creating $14 Billion Chemicals Firm

Read more

To category page

Loading...